Annual Revenue (£)

Shire revenue was £52.26 m in FY, 2017 which is a 39.3% year over year increase from the previous period.

Quarterly Revenue ($)

FY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2016FY, 2017
Revenue£5.49 m£4.65 m£14.10 m£18.22 m£26.51 m£19.24 m£20.14 m£29 m£32.38 m£119.62 m£107.97 m£98.33 m£113.95 m£111.39 m£103.42 m£109.26 m£120.61 m£122.30 m£67.07 m£47.55 m£52.26 m
Q1, 2015Q3, 2015Q2, 2016Q2, 2017
Revenue$1.49 b$1.66 b$2.43 b$3.75 b
Report incorrect company information

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Shire revenue breakdown by business segment: 11.6% from Internal Medicine, 30.2% from Immunology, 18.4% from Neuroscience, 10.0% from Genetic Diseases, 26.2% from Hematology and 3.6% from Other

FY, 2014FY, 2015FY, 2016FY, 2017
Internal Medicine1.30 b1.50 b1.76 b1.67 b
Neuroscience2.20 b2.20 b2.49 b2.66 b
Genetic Diseases2.33 b1.34 b1.39 b1.44 b
Immunology1.06 b2.83 b4.37 b
Ophthalmology54.40 m259.20 m
Oncology130.50 m261.70 m
Hematology2.24 b3.79 b
Report incorrect company information